PROMONTORY THERAPEUTICS
Live / Registered — Registered (as of 08 Oct 2024)
What this means for you
Registered since 08 Oct 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97208242
- Registration number
- 7530994
- Mark type
- Stylized text
- Filed
- 07 Jan 2022
- Published for opposition
- 22 Nov 2022
- Registered
- 08 Oct 2024
- Attorney of record
- Michael J. Leonard
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in oncology
Owner
- PROMONTORY THERAPEUTICS INC., NEW YORK, NY, US
- PROMONTORY THERAPEUTICS INC., NEW YORK, NY, US
- Phosplatin Therapeutics Inc., New York, NY, US
- Phosplatin Therapeutics Inc., New York, NY, US
Prosecution history
- 08 Oct 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 08 Oct 2024 — REGISTERED-PRINCIPAL REGISTER
- 03 Sept 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 03 Sept 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 01 Sept 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 03 Jul 2024 — USE AMENDMENT FILED
- 01 Sept 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 03 Jul 2024 — TEAS STATEMENT OF USE RECEIVED
- 15 May 2024 — ASSIGNED TO EXAMINER
- 19 Jan 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Jan 2024 — SOU EXTENSION 2 GRANTED
- 17 Jan 2024 — SOU EXTENSION 2 FILED
- 17 Jan 2024 — SOU TEAS EXTENSION RECEIVED
- 21 Jul 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Jul 2023 — SOU EXTENSION 1 GRANTED